Your browser doesn't support javascript.
loading
UroMark-a urinary biomarker assay for the detection of bladder cancer.
Feber, Andrew; Dhami, Pawan; Dong, Liqin; de Winter, Patricia; Tan, Wei Shen; Martínez-Fernández, Mónica; Paul, Dirk S; Hynes-Allen, Antony; Rezaee, Sheida; Gurung, Pratik; Rodney, Simon; Mehmood, Ahmed; Villacampa, Felipe; de la Rosa, Federico; Jameson, Charles; Cheng, Kar Keung; Zeegers, Maurice P; Bryan, Richard T; James, Nicholas D; Paramio, Jesus M; Freeman, Alex; Beck, Stephan; Kelly, John D.
Afiliação
  • Feber A; UCL Cancer Institute, University College London, London, UK.
  • Dhami P; UCL Cancer Institute, University College London, London, UK.
  • Dong L; UCL Cancer Institute, University College London, London, UK.
  • de Winter P; Division of Surgery & Interventional Science, UCL Medical School, University College London, London, UK.
  • Tan WS; Division of Surgery & Interventional Science, UCL Medical School, University College London, London, UK.
  • Martínez-Fernández M; Molecular Oncology Unit, CIEMAT (ed70A), Madrid, Spain & Biomedical Research Institute I+12, Universitary Hospistal 12 de Octubre, Av Cordoba s/n. 28041, Madrid, Spain.
  • Paul DS; Centro de Investigación, Biomédica en Red de Cáncer (CIBER ONC), Madrid, Spain.
  • Hynes-Allen A; UCL Cancer Institute, University College London, London, UK.
  • Rezaee S; Division of Surgery & Interventional Science, UCL Medical School, University College London, London, UK.
  • Gurung P; UCL Cancer Institute, University College London, London, UK.
  • Rodney S; Division of Surgery & Interventional Science, UCL Medical School, University College London, London, UK.
  • Mehmood A; School of Cancer Sciences, University of Birmingham, Birmingham, UK.
  • Villacampa F; Division of Surgery & Interventional Science, UCL Medical School, University College London, London, UK.
  • de la Rosa F; Division of Surgery & Interventional Science, UCL Medical School, University College London, London, UK.
  • Jameson C; Uro-oncology Section & Biomedical Research Institute I+12, Universitary Hospital 12 de Octubre, Av Córdoba s/n. 28041, Madrid, Spain.
  • Cheng KK; Centro de Investigación, Biomédica en Red de Cáncer (CIBER ONC), Madrid, Spain.
  • Zeegers MP; Uro-oncology Section & Biomedical Research Institute I+12, Universitary Hospital 12 de Octubre, Av Córdoba s/n. 28041, Madrid, Spain.
  • Bryan RT; Centro de Investigación, Biomédica en Red de Cáncer (CIBER ONC), Madrid, Spain.
  • James ND; Department of Histopathology, University College London Hospital, London, UK.
  • Paramio JM; Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
  • Freeman A; Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
  • Beck S; School for Public Health and Primary Care, Maastricht University, Maastricht, Netherlands.
  • Kelly JD; School of Cancer Sciences, University of Birmingham, Birmingham, UK.
Clin Epigenetics ; 9: 8, 2017.
Article em En | MEDLINE | ID: mdl-28163793

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / DNA de Neoplasias / Biomarcadores Tumorais / Metilação de DNA Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Epigenetics Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / DNA de Neoplasias / Biomarcadores Tumorais / Metilação de DNA Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Epigenetics Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Alemanha